Position in MRK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,632,721
+$105,279 QoQ
Shares Held
12,706
+0.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
#1,735
of 3,778 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Southeast Asset Advisors, LLC holds $26,273,942 across 7 Drug Manufacturers - General names. MRK ranks #5 (6.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
45,781 | $11,627,000 | |
| 2 | ABBV |
AbbVie Inc.
|
21,450 | $5,397,678 | |
| 3 | LLY |
ELI LILLY & Co
|
2,848 | $3,415,976 | |
| 4 | PFE |
Pfizer Inc
|
99,468 | $2,395,189 | |
| 5 | MRK |
Merck & Co., Inc.
This page
|
12,706 | $1,632,721 | |
| 6 | NVS |
Novartis AG
|
6,716 | $1,052,531 | |
| 7 | AMGN |
Amgen Inc
|
2,079 | $752,847 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,632,721 | 12,706 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,527,442 | 12,698 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $1,130,492 | 10,740 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,074,220 | 12,799 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $706,186 | 8,921 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $754,702 | 8,408 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $762,315 | 7,663 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $869,301 | 7,655 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $946,946 | 7,649 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $1,012,848 | 7,676 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $890,693 | 8,170 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $840,277 | 8,162 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,002,623 | 8,689 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $923,677 | 8,682 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $955,390 | 8,611 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $740,804 | 8,602 | Shares | Sole | 2022-11-04 | |
| 2022-06-30 | $780,415 | 8,560 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $701,691 | 8,552 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $671,979 | 8,768 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $447,805 | 5,962 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $483,029 | 6,211 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $478,112 | 6,202 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $506,668 | 6,194 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $513,211 | 6,187 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $479,755 | 6,204 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $399,472 | 5,192 | Shares | Sole | 2020-04-10 | |
| No filing history on record for this holder in this stock. | ||||||